BFC
TMO icon

Bedel Financial Consulting’s Thermo Fisher Scientific TMO Stock Holding History

Bedel Financial Consulting’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66
Closed -$39K – 827
2022
Q1 		$39K Sell
66
-7
-10% -$4.02K 0.01% 435
2021
Q4 		$49K Buy
73
+7
+11% +$4.37K 0.02% 397
2021
Q3 		$38K Hold
66
– – 0.01% 426
2021
Q2 		$33K Buy
66
+26
+65% +$12.3K 0.01% 459
2021
Q1 		$18K Buy
+40
New +$19.1K 0.01% 536

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bedel Financial Consulting's TMO Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 66 shares — an estimated $39K sold.

Bedel Financial Consulting first reported a position in TMO in Q1 2021 and held it in 5 quarters. The position peaked at $49K in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 66 Thermo Fisher Scientific shares in Q2 2022, an estimated $39K.
  • Bedel Financial Consulting first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 5 quarters.
  • Bedel Financial Consulting's Thermo Fisher Scientific position peaked at $49K in Q4 2021.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.